---

Top Highlights for March 2015: (Please click on read more to see details)

1. Indian Biotechnology industry is expected to reach US$100 billion by 2025 Read more
2. Sun Pharma complete Ranbaxy deal, to invest $300 mn in R&D Read more
3. UCB's Indian business to be acquired by Dr. Reddy's for $135 million Read more
4. Lupin to acquire remaining 40% stake in Pharma Dynamics, SA 
5. Natco India and Gilead in licensing agreement for hepatitis C drugs
6. Sun Pharma to acquire GSK's Opiates business Read more
7. Intas Pharma buys Combino’s hospital unit to expand its operations in Spain & Portugal Read more
8. Quantum Solutions of India to be acquired by Boston's Parexel 
9. Glenmark to set up $26 mn injectable plant in US Read more
10. DiabetOmics,US raised $5 million to set up manufacturing facility in India Read more

Aagami Updates: (Please click on hyperlink to view details)

1. Aagami's latest Company Presentation and Case Studies are available on its company website.
2. A compilation of select acquisitions made by Indian Lifesciences companies Read more